Frazier Lifesciences Acquisition Corp

Completed

Follow

Detailed Information

Information on this SPAC.

Sponsors: Frazier Lifesciences Sponsor
IPO Size: $100M
Underwriters: Credit Suisse Securities (USA)
Focus: Biotech
SEC Filings: 1828326
Public Embarc Page: https://embarc.com/capital/spac/1828326/FLAC/frazier-lifesciences-acquisition
IPO Ticker: FLAC

SPAC Leadership

Information on the SPAC leadership.

Chief Executive OfficerJames N. Topper, M.D., Ph.D.
Chief Financial OfficerDavid Topper
Vice PresidentGordon Empey
Vice PresidentMax M. Nowicki, M.D.
DirectorRobert F. Baltera
DirectorMichael F. Bigham
DirectorCarol G. Gallagher
DirectorKrishna R. Polu, M.D.
Carol G. Gallagher, Pharm.D.

Target Information

Information on the SPAC target for merger.

Company: NewAmsterdam Pharma
New Ticker: NAMS FLACU FLACW